Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Research Project (R01)
Project #
3R01HG001707-01S1
Application #
2828659
Study Section
Special Emphasis Panel (ZHG1 (O1))
Project Start
1997-09-30
Project End
2000-08-31
Budget Start
1998-07-15
Budget End
1998-08-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Stanford University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Oefner, P J (2000) Allelic discrimination by denaturing high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 739:345-55
Wagner, T M; Moslinger, R; Langbauer, G et al. (2000) Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. Br J Cancer 82:1249-53
Shen, P; Wang, F; Underhill, P A et al. (2000) Population genetic implications from sequence variation in four Y chromosome genes. Proc Natl Acad Sci U S A 97:7354-9
Wagner, T; Stoppa-Lyonnet, D; Fleischmann, E et al. (1999) Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 62:369-76
Jones, A C; Austin, J; Hansen, N et al. (1999) Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem 45:1133-40
Wagner, T M; Hirtenlehner, K; Shen, P et al. (1999) Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet 8:413-23
Wagner, T M; Moslinger, R A; Muhr, D et al. (1998) BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int J Cancer 77:354-60
Liu, W O; Oefner, P J; Qian, C et al. (1997) Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders. Genet Test 1:237-42